| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.05 |